Bicocca Open Archive

Logo unimib boa
CAZZANIGA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.456
EU - Europa 8.066
AS - Asia 3.422
SA - Sud America 44
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 13
Totale 32.046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.207
IT - Italia 1.607
IE - Irlanda 1.377
CN - Cina 1.324
SE - Svezia 1.267
SG - Singapore 1.079
DE - Germania 1.005
RU - Federazione Russa 904
UA - Ucraina 693
HK - Hong Kong 536
GB - Regno Unito 380
CA - Canada 245
FI - Finlandia 214
FR - Francia 169
VN - Vietnam 162
AT - Austria 137
TR - Turchia 97
IN - India 88
DK - Danimarca 70
BE - Belgio 60
NL - Olanda 60
ID - Indonesia 52
JP - Giappone 30
BR - Brasile 27
ES - Italia 18
EU - Europa 16
BG - Bulgaria 15
CH - Svizzera 15
IR - Iran 15
GR - Grecia 13
AU - Australia 12
CZ - Repubblica Ceca 11
NO - Norvegia 11
RO - Romania 11
AR - Argentina 10
EG - Egitto 8
KR - Corea 8
PL - Polonia 8
MU - Mauritius 6
PT - Portogallo 6
TH - Thailandia 6
CL - Cile 4
RE - Reunion 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IL - Israele 3
PH - Filippine 3
PK - Pakistan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
MX - Messico 2
RS - Serbia 2
SA - Arabia Saudita 2
SC - Seychelles 2
TW - Taiwan 2
ZA - Sudafrica 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BT - Bhutan 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
GL - Groenlandia 1
HU - Ungheria 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
TG - Togo 1
VE - Venezuela 1
Totale 32.046
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.634
Fairfield 2.292
Woodbridge 2.114
Houston 1.638
Dublin 1.345
Chandler 1.252
Ashburn 1.106
Wilmington 1.058
Singapore 918
Seattle 865
Cambridge 798
Jacksonville 755
Frankfurt am Main 752
Dearborn 605
New York 536
Hong Kong 533
Princeton 492
Milan 399
Santa Clara 274
Lawrence 239
Nanjing 227
Altamura 224
Shanghai 188
Beijing 156
San Diego 147
Vienna 135
Lachine 124
Dong Ket 80
Andover 79
Nanchang 77
Helsinki 74
Lissone 74
Toronto 69
Shenyang 63
Fuzhou 59
Guangzhou 58
Rome 57
Brussels 56
Hebei 55
Boardman 53
Jakarta 51
Changsha 48
Jinan 48
Tianjin 46
London 44
Norwalk 41
Los Angeles 37
Falls Church 34
Chicago 33
Jiaxing 32
Ningbo 29
Ottawa 28
Zhengzhou 28
Hangzhou 26
Besana In Brianza 25
Fremont 25
Pune 25
Kunming 24
Paris 24
Redmond 24
Kocaeli 23
Mountain View 23
Dallas 20
Huizen 20
Monza 20
Bologna 19
Padova 19
Turin 18
Göttingen 17
Hefei 17
San Mateo 17
Munich 16
Florence 14
Edmonton 13
Grafing 13
Sesto San Giovanni 13
Taizhou 13
Carate Brianza 12
Athens 11
Brugherio 11
Cinisello Balsamo 11
Nürnberg 11
Washington 11
Hounslow 10
Perugia 10
Romola 10
Lappeenranta 9
Leawood 9
Mariano Comense 9
Oslo 9
Phoenix 9
Verona 9
Allentown 8
Auburn Hills 8
Bari 8
Chengdu 8
Como 8
Moscow 8
São Paulo 8
University Park 8
Totale 24.842
Salva come PNG Salva come JPEG
Nome #
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 344
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 315
NIPBL: a new player in myeloid cells differentiation 304
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 300
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 287
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 286
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 275
Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis 262
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 260
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 240
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 240
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 237
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 236
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 234
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 227
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 218
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 215
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 215
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 214
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 209
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 203
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 202
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 195
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 195
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 195
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 194
Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia 192
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 191
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 190
Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response 190
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 190
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia 189
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment 188
Good outcome for very high risk adult B-cell acute lymphoblastic leukaemia carrying genetic abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if promptly submitted to allogeneic transplantation, after obtaining a good molecular remission 186
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 185
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 184
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype 182
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 181
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 180
Modeling Cornelia de Lange syndrome in vitro and in vivo reveals a role for cohesin complex in neuronal survival and differentiation 180
CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies 179
Characterization of children with FLT3-ITD acute myeloid leukemia: A report from the AIEOP AML-2002 study group 179
Clinico-biologic features of 5202 acute lymphoblastic leukemia patients enrolled in the Italian AIEOP and GIMEMA Protocols and stratified in age-cohorts 177
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". 177
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions 177
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia 176
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia 171
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model 171
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome 171
PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5 170
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 169
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients 167
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia 165
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 165
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 165
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 164
What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia? 164
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study 162
The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysis 161
Rings and bricks: Expression of cohesin components is dynamic during development and adult life 160
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias 159
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome 159
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: A retrospective analysis 159
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations 158
TEL/ARG induces cytoskeletal abnormalities in 293T cells 158
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study 158
Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol 158
Novel Chimeric Transcripts Involving PAX5 in B-Cell Precursor ALL 157
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia 156
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case 156
Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement 156
In Infant ALL with t(4;11)/MLL-AF4 Multiple and Phenotypically Distinct CD19+ BM Subsets Initiate Leukemia in NOD/SCID Mice 155
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 155
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 155
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 155
Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia 154
Fine Tuning of Surface CRLF2 Expression and Its Associated Signalling Profile in Childhood B Cell Precursor Acute Lymphoblastic Leukemia 154
Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients 153
Predictive factors of relapse and survival in childhood acute myeloid leukemia: Role of minimal residual disease 152
The bone marrow niche in b-cell acute lymphoblastic leukemia: The role of microenvironment from pre-leukemia to overt leukemia 152
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 151
PTEN opposes negative selection and enables oncogenic transformation of pre-B cells 151
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial 151
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia 149
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: Revisited in AIEOP-BFM protocol 148
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 147
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 147
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 146
The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia 145
FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia 145
Metabolic gatekeeper function of B-lymphoid transcription factors 145
Poor Prognosis for IKZF1 Intra-Gene Deletions in Pediatric Ph– B-Cell Precursor Acute Lymphoblastic Leukemia 144
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 141
T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses 140
Acute myeloid leukemia in Baraitser–Winter cerebrofrontofacial syndrome 139
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 139
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 139
SSBP2-CSF1R is a Recurrent Fusion in B-lineage Acute Lymphoblastic Leukaemia with Diverse Genetic Presentation and Variable Outcome 139
Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia 138
The role of PAX5 in ALL 136
Totale 18.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.043 0 0 0 0 651 776 796 450 553 343 317 157
2020/20215.491 222 341 432 474 446 436 816 678 399 494 350 403
2021/20223.278 232 342 419 237 256 271 123 177 208 230 227 556
2022/20235.119 663 1.625 374 426 282 793 67 292 332 31 154 80
2023/20244.081 119 130 173 185 528 1.087 816 152 357 85 81 368
2024/20252.670 466 1.067 552 447 138 0 0 0 0 0 0 0
Totale 33.172